Friday, January 22, 2021
wellness India Expo
Home Tags Bharat Biotech

Tag: Bharat Biotech

Wait over as DCGI approves Bharat Biotech & Serum Institute COVID-19...

After adequate examination, Central Drugs Standard Control Organisation decided to accept the recommendations of the Expert Committee, and accordingly, vaccines of Serum and Bharat Biotech are being approved for restricted use in an emergency situation

PM Modi visits India’s top private vaccine manufacturing facilities

On 28th November, Prime Minister of India, Narendra Modi undertook a three-city tour to the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and Serum Institute of India in Pune......................

Bharat Biotech’s COVID-19 vaccine ‘COVAXIN’ gets DCGI nod, human trials to...

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

IVI & Bharat Biotech get US $14.1 million from CEPI to...

The Coalition for Epidemic Preparedness Innovations (CEPI) will provide consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) with up to US$14.1 million for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya..............

COVID-19: India bets big on monoclonal antibodies amid mega industry &...

CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................

Chiron Behring re-launches its rabies vaccine as Chirorab

Earlier marketed under the trade name Rabipur®, this vaccine is presently manufactured using the same technology at the same site..................

Hilleman Labs licenses oral cholera vaccine ‘Hillchol’ to Bharat Biotech

Collaboration seeks to accelerate the development, licensure, manufacture and supply of an affordable, next-generation Cholera vaccine to support access in low and middle-income countries.................

Bharat Biotech set to acquire Chiron Behring Vaccines from GSK

The Ankleshwar, Gujarat based Chiron Behring Vaccines which is a part of GlaxoSmithKline Asia will be acquired by Bharat Biotech in an all cash transaction, subject to a number of closing conditions which both the parties intend to complete in the coming weeks................

Bharat Biotech receives National Technology Award for ROTAVAC from the President

Launched in 2015 by the Prime Minister of India, Narendra Modi ROTAVAC vaccine was introduced into the Universal Immunization Program in India during 2016, with initial implementation in 9 states with more States in the pipeline.............

India needs to follow its own model of innovation: Dr Krishna...

The Chairman of Bharat Biotech, Dr Krishna Ella in his remarks at the 6th Foundation Day event of the BIRAC at New Delhi, mentioned that the Indian biotech sector must create its own indigenous model for innovation that would cater to its needs and that of the world............